Literature DB >> 25249813

Recurrent angiomatoid fibrous histiocytoma: a case report and review of the literature.

Mary E Huerter1, Rasheed Hammadeh2, Quan Zhou3, Adam I Riker4.   

Abstract

BACKGROUND: Angiomatoid fibrous histiocytoma (AFH) is a rare soft-tissue tumor with intermediate malignant potential. It most commonly occurs in children and young adults. CASE REPORT: We report a case of a recurrent AFH of the back, locally recurring within 14 months of the original operation. We also review the literature for this uncommon entity. The patient underwent a wide resection of the recurrent AFH, obtaining negative surgical margins. Postoperatively, he has done well.
CONCLUSION: Twelve months since his re-excision, the patient shows no evidence of recurrence to date. He is seen every 6 months for continued clinical examinations.

Entities:  

Keywords:  Histiocytoma–angiomatoid fibrous; neoplasm recurrence–local

Year:  2014        PMID: 25249813      PMCID: PMC4171805     

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  20 in total

1.  Angiomatoid fibrous histiocytoma: staging and evaluation of response to therapy with F-18 FDG PET/CT.

Authors:  William Makis; Anthony Ciarallo; Marc Hickeson; Vilma Derbekyan
Journal:  Clin Nucl Med       Date:  2011-05       Impact factor: 7.794

2.  Angiomatoid "malignant" fibrous histiocytoma: a clinicopathologic study of 158 cases and further exploration of the myoid phenotype.

Authors:  J C Fanburg-Smith; M Miettinen
Journal:  Hum Pathol       Date:  1999-11       Impact factor: 3.466

3.  Evaluation of CD68 and other histiocytic antigens in angiomatoid malignant fibrous histiocytoma.

Authors:  M E Smith; M J Costa; S W Weiss
Journal:  Am J Surg Pathol       Date:  1991-08       Impact factor: 6.394

Review 4.  The evolving classification of soft tissue tumours: an update based on the new WHO classification.

Authors:  C D M Fletcher
Journal:  Histopathology       Date:  2006-01       Impact factor: 5.087

Review 5.  Tumors with EWSR1-CREB1 and EWSR1-ATF1 fusions: the current status.

Authors:  Khin Thway; Cyril Fisher
Journal:  Am J Surg Pathol       Date:  2012-07       Impact factor: 6.394

6.  Angiomatoid fibrous histiocytoma of the arm treated by radiotherapy for local recurrence--case report.

Authors:  M A Costa; I Silva; L Carvalhido; I Azevedo; L Alves; C Leal; C Lopes; S Borges; E Vieira
Journal:  Med Pediatr Oncol       Date:  1997-05

7.  EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma.

Authors:  Sabrina Rossi; Kàroly Szuhai; Marije Ijszenga; Hans J Tanke; Lucia Zanatta; Raf Sciot; Christopher D M Fletcher; Angelo P Dei Tos; Pancras C W Hogendoorn
Journal:  Clin Cancer Res       Date:  2007-12-15       Impact factor: 12.531

Review 8.  MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century.

Authors:  Igor Matushansky; Elizabeth Charytonowicz; Joslyn Mills; Sara Siddiqi; Todd Hricik; Carlos Cordon-Cardo
Journal:  Expert Rev Anticancer Ther       Date:  2009-08       Impact factor: 4.512

9.  Primary intracerebral angiomatoid fibrous histiocytoma: report of a case with a t(12;22)(q13;q12) causing type 1 fusion of the EWS and ATF-1 genes.

Authors:  Christopher Dunham; Jerry Hussong; Michael Seiff; John Pfeifer; Arie Perry
Journal:  Am J Surg Pathol       Date:  2008-03       Impact factor: 6.394

10.  Angiomatoid fibrous histiocytoma.

Authors:  L D Grossman; R R White; D A Arber
Journal:  Ann Plast Surg       Date:  1996-06       Impact factor: 1.539

View more
  2 in total

1.  A Case of Angiomatoid Fibrous Histiocytoma Presenting as Subcutaneous Nodule in a 4-Year-Old Girl.

Authors:  Hyun Ji Kang; Chong Hyun Won; Mi Woo Lee; Jee Ho Choi; Woo Jin Lee
Journal:  Ann Dermatol       Date:  2018-02-21       Impact factor: 1.444

2.  Intracranial angiomatoid fibrous histiocytoma: report of a rare case.

Authors:  Alireza Tabibkhooei; Leila Asgarzadeh; Alireza Sadeghipour; Mohammad Vafaee Shahi
Journal:  Iran J Child Neurol       Date:  2022-07-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.